AMLODIPINE BESYLATE
- Product NDC
- 55700-740
- 11-digit product format
- 557000740
- Labeler code
- 55700
- Product ID
- 55700-740_257b7523-1f66-4a34-ba4a-e79bc7b0b5db
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- AMLODIPINE BESYLATE
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Quality Care Products, LLC
- Application
- ANDA077516
- Marketing category
- ANDA
- Marketing start
- 2019-04-05
- Marketing end
- 0000-00-00
- Substance
- AMLODIPINE BESYLATE
- Active strength
- 10 mg/1
- Pharmacologic classes
- Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [CS]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 55700-740 | D | Discontinued by firm | 2026-07-31 | ||
| excluded package | package | 55700-740 | 55700-740-30 | D | Discontinued by firm | 2026-07-31 | |
| excluded package | package | 55700-740 | 55700-740-90 | D | Discontinued by firm | 2026-07-31 |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A077516-001 | AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | EQ 2.5MG BASE | TABLET / ORAL | 2007-07-11 | ||
| A077516-002 | AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | EQ 5MG BASE | TABLET / ORAL | 2007-07-11 | ||
| A077516-003 | AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | EQ 10MG BASE | TABLET / ORAL | 2007-07-11 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A077516-001 | AMLODIPINE BESYLATE | EQ 2.5MG BASE | TABLET / ORAL | 2007-07-11 | a50c72e98297… | ||
| 2026-08-01 22:54:32 | 2026-06 | A077516-002 | AMLODIPINE BESYLATE | EQ 5MG BASE | TABLET / ORAL | 2007-07-11 | a50c72e98297… | ||
| 2026-08-01 22:54:32 | 2026-06 | A077516-003 | AMLODIPINE BESYLATE | EQ 10MG BASE | TABLET / ORAL | 2007-07-11 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | Bryant Ranch Prepack | cb3da88f-cee0-4c22-9760-a50edc8fc140 | 2023-03-27 | Warnings, Adverse reactions | 077516 ANDA077516 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 55700-740-30 | EA - Each | 55700-740 | 11a9a236-8444-4551-851e-8f10a6daa2fa | 1 | 2019-05-02 |
| 55700-740-90 | EA - Each | 55700-740 | 9ed3e7fd-ab25-4da0-a04a-5fd80a7470eb | 1 | 2019-05-02 |